• Activity INFORMATION

  Overview

  This session is part of the Opioid Module, which explores the safe and effective utilization of prescription opioids within diverse pain management treatment plans during the opioid crisis. This session seeks to explore appropriate patient recommendations regarding opioid interactions using both the pharmacological aspects, including enzymes and transporters, QTc interval changes, and overlapping serotonergic effects; and patient diversity aspects including pharmacogenomics, gender, and age. This session will also review the powerful impact drug-drug sedative interactions have on the increased risk of adverse effects such as general patient harm, additive sedation, and overdose. 
  

  Handouts

  • Slide Document :   22030H08_2pp.pdf Download

  • Slide Document :   22030H08_6pp.pdf Download

  Financial Support By

  PharmCon

• Learning OBJECTIVES

  Pharmacist

  Identify appropriate patient recommendations regarding opioid interactions involving pharmacological aspects including enzymes and transporters, QTc interval changes, and overlapping serotonergic effects

  Recognize the powerful impact drug-drug sedative interactions have on the increased risk of adverse effects such as general patient harm, additive sedation, and overdose

  Identify appropriate patient recommendations regarding opioid interactions involving patient diversity aspects including pharmacogenomics, gender, and age

• Activity ACCREDITATION

  Activity Type

  Application

  CE Broker

  20-895218

  Universal Activity Number

  Pharmacist 0798-0000-22-030-H08-P
  

  PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

  PharmCon is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

  In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.

• Activity INSTRUCTION

  Faculty

  Mark  Garofoli, PharmD, MBA, BCGP, CPE, CTTS Assistant Professor, West Virginia University School of Pharmacy

This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).